Close
4

Evonik Evonik

X

Company profile for NephroDI Therapeutics

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
NephroDI Therapeutics is developing a novel AMPK activator as a first-in-class potential therapy for Nephrogenic Diabetes Insipidus (NDI). The genesis of this technology began with Drs. Jeff Sands and Janet Klein, recognized clinical and research leaders in kidney diseases. While NDI patients are now living longer lives with fewer cognitive deficits, the quality of their lives remains diminished. Drs. Sand and Klein were inve...
NephroDI Therapeutics is developing a novel AMPK activator as a first-in-class potential therapy for Nephrogenic Diabetes Insipidus (NDI). The genesis of this technology began with Drs. Jeff Sands and Janet Klein, recognized clinical and research leaders in kidney diseases. While NDI patients are now living longer lives with fewer cognitive deficits, the quality of their lives remains diminished. Drs. Sand and Klein were investigating the role of AMPK activators as a promising potential therapy to reduce urine volume in NDI patients.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
NephroDI Therapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
Philadelphia, PA 19103
Telephone
Telephone
+1 857-891-0017
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY